News

Medical Xpress21d
A type of immune cell strengthens immunotherapy and prevents tumor relapse in animal models
In contrast, this dendritic cell-based immunotherapy aims to induce a new, specific immune response against the tumor." Describing the strategy, study co-supervisor Stefanie Wculek—formerly at ...
Monthly Prescribing Reference21d
Emactuzumab Fast Tracked for Tenosynovial Giant Cell Tumor
Results from a phase 1 trial showed the independently reviewed best overall objective response rate was 71% in emactuzumab-treated patients. The Food and Drug Administration (FDA) has granted Fast ...
Cancer Research27d
CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
1Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China. 2Department of Head and Neck Oncology, State Key Laboratory of ...
Frontiers28d
T-cell receptor dynamics in digestive system cancers: a multi-layer machine learning approach for tumor diagnosis and staging
Background: T-cell receptor (TCR) repertoires provide insights into tumor immunology, yet their variations across digestive system cancers are not well understood. Characterizing TCR differences ...
Cancer Research29d
Activated T cells break tumor immunosuppression by macrophage re-education
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...